1. Home
  2. LGO vs TIL Comparison

LGO vs TIL Comparison

Compare LGO & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGO

Largo Inc.

HOLD

Current Price

$1.23

Market Cap

87.5M

Sector

N/A

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.13

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
TIL
Founded
1988
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
74.7M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
LGO
TIL
Price
$1.23
$7.13
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$3.30
$125.00
AVG Volume (30 Days)
561.5K
255.4K
Earning Date
11-12-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$111,884,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$53.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$5.67
52 Week High
$2.70
$42.79

Technical Indicators

Market Signals
Indicator
LGO
TIL
Relative Strength Index (RSI) 63.23 31.20
Support Level $1.05 $6.91
Resistance Level $1.24 $7.42
Average True Range (ATR) 0.09 0.69
MACD 0.03 -0.30
Stochastic Oscillator 90.81 20.30

Price Performance

Historical Comparison
LGO
TIL

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: